The aim of the current work was to investigate the potential role of GAS6, AXL, GAS6-AS1, and GAS6-DT in type 2 diabetes development and progression to DN, as well as their potential utility as biomarkers for DN in Egyptian patients. This evidence concerns the gene AXL and type 2 diabetes mellitus.